山东药玻：10月25日召开董事会会议

Group 1 - The core point of the article is that Shandong Pharmaceutical Glass (SH 600529) held its 11th third board meeting on October 25, 2025, to review the company's Q3 2025 report and other documents [1] - For the year 2024, Shandong Pharmaceutical Glass's revenue composition is as follows: manufacturing accounts for 90.58%, trade services for 8.14%, and other businesses for 1.28% [1] - As of the report, Shandong Pharmaceutical Glass has a market capitalization of 14.1 billion yuan [1]